https://www.selleckchem.com/ph....armacological_epigen
However, in the case of side effects, therapeutic failure or the need for long-term use, anabolic agents may be considered. In high-risk patients, anabolic agents may be considered as an initial therapeutic option. The combination of antiresorptive and anabolic agents may be useful to increase BMD compared with monotherapy, but more information is warranted to determine the effects on fracture risk. To explore the demographic and clinical features of severe catatonic patients, comparing responders and non-responders to ECT in
Like
Comment
Share
